GlaxoSmithKline Company Profile

14:49 EDT 25th May 2016 | BioPortfolio

We have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world. In fact, we are the only pharmaceutical company to tackle the World Health Organization’s three ‘priority’ diseases – HIV/AIDS, tuberculosis and malaria.
Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.


980 Great West Road
United States of America


Phone: +1 888 825 5249 or +1 888 825 5249

News Articles [577 Associated News Articles listed on BioPortfolio]

GlaxoSmithKline CEO would consider dividing following the Novartis deal

Should GlaxoSmithKline split up into various smaller companies? Investor Neil Woodford thinks so.

Asthma drug from GlaxoSmithKline approved in Europe

The European Commission granted approval to GlaxoSmithKline's Nucala, or mepolizumab, as an add-on treatment for severe refra -More- 

GlaxoSmithKline back on track for core growth, as 4th-qtr beats expectations

GlaxoSmithKline today post financials that beat analysts’ forecasts and suggest the company, which…

GlaxoSmithKline: explodiert bald der Gewinn?

GlaxoSmithKline (GSK) gehört zu den weltweit führenden Pharmakonzernen. Bei rezeptpflichtigen Medikamenten liegt der Fokus auf Atemwegserkrankungen und HIV. Daneben stellt der Konzern Impfstoffe un....

Glaxosmithkline übertrifft die Erwartungen

Von Denise Roland LONDON (Dow Jones)--Der britische Pharmakonzern Glaxosmithkline hat im ersten Quartal nur einen Bruchteil des Vorjahresgewinns erzielt. Im Vorjahreszeitraum hatte der Konzern inf...

GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia

Today, GlaxoSmithKline (GSK) responded to the recently released Senate Committee on Finance January 2010 Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia (the Staff Report) by releasing ...

GlaxoSmithKline: A Positive Outlook For 2016

GlaxoSmithKline is one of the world's leading pharmaceutical companies, with a market cap in excess of $94 billion. Throughout 2015 GSK performed strongly whilst expanding its strengths into a variety...

Glaxosmithkline muss 37,61 Millionen Pfund Strafe zahlen

Von Ian Walker LONDON (Dow Jones)--Mit Geld und Vergünstigungen hat Glaxosmithkline Kartellwächtern zufolge den Marktstart von Nachahmerprodukten für sein Antidepressivum Paroxetin in Großbritanni...

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Human papillomavirus vaccine trials and tribulations: Vaccine efficacy.

As of December 2014, there were 3 approved vaccines for human papillomavirus (HPV): bivalent Cervarix (GlaxoSmithKline, New York, NY), quadrivalent Gardasil (Merck and Co, Kenilworth, NJ), and 9-valen...

Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.

Inactivated trivalent influenza vaccines (IIV3s) are designed to protect against illness caused by two influenza A virus subtypes and one influenza B virus lineage. They may provide inadequate protect...

Fluticasone furoate/vilanterol combination for the treatment of COPD and asthma.

The critical role of the combination therapy of an inhaled corticosteroid (ICS) and a long-acting β-adrenoceptor agonist (LABA) in the treatment of patients suffering from asthma and also severe chro...

Identification of β-hematin inhibitors in the MMV Malaria Box.

The Malaria Box, assembled by the Medicines for Malaria Venture, is a set of 400 structurally diverse, commercially available compounds with demonstrated activity against blood-stage Plasmodium falcip...

Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series.

On January 14, 2016, GlaxoSmithKline Biologicals (Research Triangle Park, North Carolina) received approval from the Food and Drug Administration (FDA) to expand use of Hiberix (Haemophilus b Conjugat...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to assess the immunogenicity and safety of Gla...

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to evaluate the safety and immunogenicity of G...

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

The present study is designed to assess the lot-to-lot consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza candidate vaccine (GSK1562902A) in adults age...

ARIXTRA® Adherence in SVT Patients.

Fondaparinux is an anticoagulant used in the prevention and treatment of thromboembolic disease. It has recently been approved in the European Union (EU) for the treatment of patients with...

Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A

The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' investigational Herpes Zoster vaccine GSK1437173A when administered as...

Companies [64 Associated Companies listed on BioPortfolio]

GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation pro...

GlaxoSmithKline & Prosensa

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enablin...

NC GlaxoSmithKline Foundation

GlaxoSmithKline plc

One of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and liv...

North Carolina GlaxoSmithKline Foundation

More Information about "GlaxoSmithKline" on BioPortfolio

We have published hundreds of GlaxoSmithKline news stories on BioPortfolio along with dozens of GlaxoSmithKline Clinical Trials and PubMed Articles about GlaxoSmithKline for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GlaxoSmithKline Companies in our database. You can also find out about relevant GlaxoSmithKline Drugs and Medications on this site too.

Quick Search

Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record